DXR
Daxor Corp (DXR)
Healthcare • NASDAQ • $9.95+3.00%
- Symbol
- DXR
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $9.95
- Daily Change
- +3.00%
- Market Cap
- $57.98M
- Trailing P/E
- 6.07
- Forward P/E
- N/A
- 52W High
- $14.76
- 52W Low
- $7.19
- Analyst Target
- $22.50
- Dividend Yield
- N/A
- Beta
- 0.29
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.
Company websiteResearch DXR on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.